Item 5.07 Submission of Matters to a Vote of Security Holders.

At the 2022 Annual General Meeting of Shareholders (the "Annual Meeting") of RVL Pharmaceuticals plc (the "Company") held on June 16, 2022, the Company's shareholders voted on the following proposals:

· Election of the directors of the Company, each to serve a term extending until

the conclusion of the Company's next annual general meeting of shareholders;

· Ratification, in a non-binding advisory vote, of the appointment of Ernst &

Young LLP as the independent registered public accounting firm of the Company
   for the year ending December 31, 2022, and authorization, in a binding vote, of
   the Company's board of directors, acting through the audit committee, to set
   the independent registered public accounting firm's remuneration; and

· Approval of a waiver of offer obligations under Rule 9 of the Irish Takeover


   Rules to enable acquisition of shares by the Company's major shareholders and
   certain members of its management team.

The final voting results for the Annual Meeting are as follows:





1.    The Company's shareholders elected Brian Markison, Joaquin Benes, David
Burgstahler, Gregory L. Cowan, Michael DeBiasi, Sriram Venkataraman and Juan
Vergez as directors, each to serve a term extending until the conclusion of the
Company's next annual general meeting of shareholders or until his successor is
duly elected and qualified or until his death, resignation or removal, based on
the following votes:



                                                                       Broker
                          For            Against        Abstain       Non-Votes
Brian Markison          63,222,617        320,044        321,178       8,959,629

Joaquin Benes           60,694,113       2,739,565       430,161       8,959,629

David Burgstahler       60,735,617       2,699,108       429,114       8,959,629

Gregory L. Cowan        62,977,297        402,404        484,138       8,959,629

Michael DeBiasi         63,058,279        374,377        431,183       8,959,629

Sriram Venkataraman     63,053,715        299,471        510,653       8,959,629

Juan Vergez             58,199,214       5,357,824       306,801       8,959,629

2. The Company's shareholders ratified, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2022, and authorized, in a binding vote, the Company's board of directors, acting through the audit committee, to set the independent registered public accounting firm's remuneration, based on the following votes:





   For       Against   Abstain
71,892,258   813,415   117,795

3. The independent shareholders approved a waiver of offer obligations under Rule 9 of the Irish Takeover Rules to enable acquisition of shares by the Company's major shareholders and certain members of its management team, based on the following votes:





   For        Against     Abstain
28,894,940   1,340,770   1,357,185

© Edgar Online, source Glimpses